Respiratory complications before and after liver transplant are common, diverse, and potentially have a negative impact on patient outcomes. In this review, we discuss the most frequent respiratory conditions that patients may develop in the perioperative period. Their prevention and/or treatment may help to maximize the benefit these patients may derive from liver transplant. This review examines diagnostic and therapeutic approaches to these complications for hepatologists, surgeons, and critical care physicians.
MateiDPascaSDavidA. Hepatic hydrothorax in patients with cirrhosis and ascites—its prevalence and association with other cirrhosis complications. J Hepatol. 2017;66(1):S135.
2.
ChenTALoGHLaiKH. Risk factors for spontaneous bacterial empyema in cirrhotic patients with hydrothorax. J Chin Med Assoc. 2003;66(10):579–586.
3.
KrokKLCárdenasA. Hepatic hydrothorax. Semin Respir Crit Care Med. 2012;33(1):3–10.
4.
HewettLJBradshawMLGordonLLRockeyDC. Diagnosis of isolated hepatic hydrothorax using peritoneal scintigraphy. Hepatology. 2016;64(4):1364–1366.
5.
ZendaTMiyamotoSMurataSMabuchiH. Detection of diaphragmatic defect as the cause of severe hepatic hydrothorax with magnetic resonance imaging. Am J Gastroenterol. 1998;93(11):2288–2289.
6.
HuangPMChangYLYangCYLeeYC. The morphology of diaphragmatic defects in hepatic hydrothorax: thoracoscopic finding. J Thorac Cardiovasc Surg2005;130(1):141–145.
7.
MammarappallilJGAndersonSADanelsonKAStitzelJAChilesC. Estimation of pleural fluid volumes on chest radiography using computed tomography volumetric analysis: an update of the visual prediction rule. J Thorac Imaging. 2015;30(5):336–339.
8.
SvigalsPZChopraARavenelJGNietertPJHugginsJT. The accuracy of pleural ultrasonography in diagnosing complicated parapneumonic pleural effusions. Thorax. 2017;72(1):94–95.
9.
XiolXCastellvíJMGuardiolaJ. Spontaneous bacterial empyema in cirrhotic patients: a prospective study. Hepatology. 1996;23(4):719–723.
10.
MooreKPWongFGinesP. The management of ascites in cirrhosis: report on the consensus conference of the international ascites club. Hepatology. 2003;38(1):258–266.
11.
OrmanESLokAS. Outcomes of patients with chest tube insertion for hepatic hydrothorax. Hepatol Int. 2009;3(4):582–586.
Sharaf-EldinMBediwyASKobtanA. Pigtail catheter: a less invasive option for pleural drainage in egyptian patients with recurrent hepatic hydrothorax. Gastroenterol Res Pract. 2016;2016:4013052.
14.
DitahICAl BawardyBFSaberiBDitahCKamathPS. Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax: a systematic review and cumulative meta-analysis. World J Hepatol. 2015;7(13):1797–1806.
15.
DhanasekaranRWestJKGonzalesPC. Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis. Am J Gastroenterol. 2010;105(3):635–641.
16.
HouFQiXGuoX. Effectiveness and safety of pleurodesis for hepatic hydrothorax: a systematic review and meta-analysis. Dig Dis Sci. 2016;61(11):3321–3334.
17.
JungY.Surgical treatment of hepatic hydrothorax: a “Four-Step Approach.”Ann Thorac Surg. 2016;101(3):1195–1197.
18.
XiolXTremosaGCastelloteJ. Liver transplantation in patients with hepatic hydrothorax. Transpl Int. 2005;18(6):672–675.
19.
SerstéTMorenoCFrancozC. The impact of preoperative hepatic hydrothorax on the outcome of adult liver transplantation. Eur J Gastroenterol Hepatol. 2010;22(2):207–212.
20.
VoiosuAMDahaICVoiosuTA. Prevalence and impact on survival of hepatopulmonary syndrome and cirrhotic cardiomyopathy in a cohort of cirrhotic patients. Liver Int. 2015;35(12):2547–2555.
21.
PascasioJMGriloILópez-PardoFJ. Prevalence and severity of hepatopulmonary syndrome and its influence on survival in cirrhotic patients evaluated for liver transplantation. Am J Transplant. 2014;14(6):1391–1399.
22.
MachicaoVIBalakrishnanMFallonMB. Pulmonary complications in chronic liver disease. Hepatology. 2014;59(4):1627–1637.
23.
FallonMBAbramsGALuoBHouZDaiJKuDD. The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome. Gastroenterology. 1997;113:606–614.
24.
ZhangJLuoBTangL. Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome. Gastroenterology. 2009;136:1070–1080.
25.
KrowkaMJFallonMBKawutSM. International liver transplant society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension. Transplantation. 2016;100(7):1440–1452.
26.
KrowkaMJWiesnerRHHeimbachJK. Pulmonary contraindications, indications, and MELD exceptions for liver transplantation: a contemporary view and look forward. J Hepatol. 2013;59(2):367–374.
27.
KrowkaMJWisemanGABurnettOL. Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO(2) response to 100% oxygen, and brain uptake after (99 m)Tc MAA lung scanning. Chest. 2000;118(3):615–624.
28.
GuptaSCastelHRaoRV. Improved survival after liver transplantation in patients with hepatopulmonary syndrome. Am J Transplant. 2010;10(2):354–363.
29.
GoldbergDSKrokKBatraSTrotterJFKawutSMFallonMB. Impact of the hepatopulmonary syndrome MELD exception policy on outcomes of patients after liver transplantation: an analysis of the UNOS database. Gastroenterology. 2014;146(5):1256–1265.
30.
KrowkaMJSwansonKLFrantzRP. Portopulmonary hypertension: results from a 10-year screening algorithm. Hepatology. 2006;44(6):1502–1510.
31.
Rodríquez-RoisinRKrowkaMJHervéPFallonMB; ERS (European Respiratory Society) Task Force-PHD Scientific Committee. Highlights of the ERS Task Force on pulmonary-hepatic vascular disorders (PHD). J Hepatol. 2005;42(6):924–927.
32.
Rodríguez-RoisinRKrowkaMJHervéPFallonMB; ERS Task Force Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee. Pulmonary-hepatic vascular disorders (PHD). Eur Respi. J. 2004;24(5):861–880.
33.
KrowkaMJFrantzRPMcGoonMDSeversonCPlevakDJWiesnerRH. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension. Hepatology. 1999;30(3):641–648.
34.
FixOKBassNMDe MarcoTMerrimanRB. Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol. Liver Transpl. 2007;13(6):875–885.
35.
HoeperMMSeyfarthHJHoeffkenG. Experience with inhaled iloprost and bosentan in portopulmonary hypertension. Eur Respir J. 2007;30:1096–1102.
36.
Cartin-CebaRSwansonKIyerVWiesnerRHKrowkaMJ. Safety and efficacy of ambrisentan for the treatment of portopulmonary hypertension. Chest. 2011;139(1):109–114.
37.
SwansonKLWiesnerRHNybergSLRosenCBKrowkaMJ. Survival in portopulmonary hypertension: Mayo clinic experience categorized by treatment subgroups. Am J Transplant. 2008;8(11):2445–2453.
38.
KrowkaMJPlevakDJFindlayJYRosenCBWiesnerRHKromRA. Pulmonary hemodynamics and perioperative cardiopulmonary related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl. 2000;6(4):443–450.
39.
SavaleLSattlerCCoillyAContiFRenardSFrancozCBouvaistHFerayCBorentainPJaïsXMontaniD. Long-term outcome in liver transplantation candidates with portopulmonary hypertension. Hepatology. 2017;65(5):1683–1692.
40.
DeMartinoESCartin-CebaRFindlayJYHeimbachJKKrowkaMJ. Frequency and outcomes of patients with increased mean pulmonary artery pressure at the time of liver transplantation. Transplantation. 2017;101(1):101–106.
41.
de SerresFJBlancoIFernandez-BustilloE. PI S and PI Z alpha-1 antitrypsin deficiency worldwide. A review of existing genetic epidemiological data. Monaldi Arch Chest Dis. 2007;67:184–208.
42.
KemmerNKaiserTZachariasVNeffGW. Alpha-1-antitrypsin deficiency: outcomes after liver transplantation. Transplant Proc. 2008;40(5):1492–1494.
CareyEJIyerVNNelsonDRNguyenJHKrowkaMJ. Outcomes for recipients of liver transplantation for alpha-1-antitrypsin deficiency–related cirrhosis. Liver Transpl. 2013;19(12):1370–1376.
45.
American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003;168(7):818–900.
46.
LuisettiMFerrarottiICordaL. Italian registry of patients with alpha-1 antitrypsin deficiency: general data and quality of life evaluation. COPD. 2015;12Suppl 1:52–57.
47.
BangaAGildeaTRajeswaranJRokadiaHBlackstoneEHStollerJK. The natural history of lung function after lung transplantation for α(1)-antitrypsin deficiency. Am J Respir Crit Care Med. 2014;190(3):274–281.
48.
JalanRFernandezJWiestR. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol. 2014;60(6):1310–1324.
49.
FernándezJAcevedoJCastroM. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology. 2012;55(5):1551–1561.
50.
LevesqueEHotiEAzoulayD. Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit. J Hepatol. 2012;56(1):95–102.
51.
RolandoNHarveyFBrahmJ. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology. 1990;11(1):49–53.
KarvellasCJCavazosJBattenhouseH; US Acute Liver Failure Study Group. Effects of antimicrobial prophylaxis and blood stream infections in patients with acute liver failure: a retrospective cohort study. Clin Gastroenterol Hepatol. 2014;12(11):1942–1949.
54.
HungTHTsengCWHsiehYHTsengKCTsaiCCTsaiCC. High mortality of pneumonia in cirrhotic patients with ascites. BMC Gastroenterol. 2013;13:25.
55.
LevesqueESalibaFIchaïPSamuelD. Outcome of patients with cirrhosis requiring mechanical ventilation in ICU. J Hepatol. 2014;60(3):570–578.
56.
OlsonJCKarvellasCJ. Critical care management of the patient with cirrhosis awaiting liver transplant in the intensive care unit. Liver Transpl. 2017;23(11):1465–1476.
57.
KokBKarvellasCJAbraldesJG; Cooperative antimicrobial therapy of septic shock (CATSS) research group. The impact of obesity in cirrhotic patients with septic shock: a retrospective cohort study. Liver Int. 2017;28(7):1230–1241.
58.
ReddyKRO’LearyJGKamathPS; North American Consortium for the Study of End-Stage Liver Disease. High risk of delisting or death in liver transplant candidates following infections: results from the North American Consortium for the study of end-stage liver disease. Liver Transpl. 2015;21(7):881–888.
59.
PedersenMRChoiMBrinkJASeetharamAB. Pretransplant factors and associations with postoperative respiratory failure, ICU length of stay, and short-term survival after liver transplantation in a high MELD population. J Transplant. 2016;2016:6787854.
60.
SinghNGayowskiTWagenerMMMarinoIR. Pulmonary infiltrates in liver transplant recipients in the intensive care unit. Transplantation. 1999;67(8):1138–1144.
UlubayGKirnapMEr DedekarginogluBKupeliEOner EyubogluFHaberalM. Awareness of respiratory failure can predict early postoperative pulmonary complications in liver transplant recipients. Exp Clin Transplant. 2015;13(suppl 3):110–114.
63.
SnowdenCPHughesTRoseJRobertsDR. Pulmonary edema in patients after liver transplantation. Liver Transpl. 2000;6(4):466–470.
64.
AdetiloyeVAJohnPR. Intervention for pleural effusions and ascites following liver transplantation. Pediatr Radiol. 1998;28(7):539–543.
65.
CardosoFSKarvellasCJKnetemanNMMeebergGFidalgoPBagshawSM. Respiratory rate at intensive care unit discharge after liver transplant is an independent risk factor for intensive care unit readmission within the same hospital stay: a nested case-control study. J Crit Care. 2014;29(5):791–796.
66.
WeissEDahmaniSBertF. Early-onset pneumonia after liver transplantation: microbiological findings and therapeutic consequences. Liver Transpl. 2010;16(10):1178–1185.
67.
SanerFHOlde DaminkSWPavlakovicG. Pulmonary and blood stream infections in adult living donor and cadaveric liver transplant patients. Transplantation. 2008;85(11):1564–1568.
68.
LevesqueEHotiEAzoulayD. Pulmonary complications after elective liver transplantation-incidence, risk factors, and outcome. Transplantation. 2012;94(5):532–538.
69.
KleinmanSCaulfieldTChanP. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion. 2004;44(12):1774–1789.
70.
MoritaYPrettoEAJr. Increased incidence of transfusion-related acute lung injury during orthotopic liver transplantation: a short report. Transplant Proc. 2014;46(10):3593–3597.
71.
LooneyMRGropperMAMatthayMA. Transfusion-related acute lung injury: a review. Chest. 2004;126(1):249–258.
LooneyMRRoubinianNGajicO; Transfusion-Related Acute Lung Injury Study Group. Prospective study on the clinical course and outcomes in transfusion-related acute lung injury. Crit Care Med. 2014; 42(7):1676–1687.
